97 Results

People

  1. Hellmann
    Hellmann
  2. Rosenberg
    Rosenberg
  3. Rekhtman
    Rekhtman
  4. Rizvi
    Rizvi
  5. Funt
    Funt
  6. Travis
    Travis
  7. Chaft
    Chaft
  8. Chen
    Chen
  9. D'Angelo
    D'Angelo
  10. Iyer
    Iyer

Groups

  1. Department of Medicine (63)
  2. Solid Tumor Oncology Division (56)
  3. Thoracic Oncology (21)
  4. Department of Pathology and Laboratory Medicine (20)
  5. GSK Faculty (16)
  6. Hematologic Malignancies, Division of (16)
  7. Weinberg Fellows (14)
  8. Sloan Kettering Institute Postdocs (13)
  9. Genitourinary Oncology Service (12)
  10. Gastrointestinal Oncology Service (11)
  1. "pd-l1"
Formats
  1. Journal Article (67)
  2. Meeting Abstract (13)
  3. Review (13)
  4. Book Section (2)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (63)
  2. Solid Tumor Oncology Division (56)
  3. Thoracic Oncology (21)
  4. Department of Pathology and Laboratory Medicine (20)
  5. GSK Faculty (16)
  6. Hematologic Malignancies, Division of (16)

More Groups

People
  1. Matthew Hellmann (10)
  2. Jamie Chaft (6)
  3. Jonathan Rosenberg (6)
  4. Naiyer Rizvi (5)
  5. Natasha Rekhtman (5)
  6. Geoffrey Ku (4)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (6)
  4. 2022 (8)
  5. 2021 (12)
  6. 2020 (11)

More Years

Publications
  1. Journal of Thoracic Oncology (16)
  2. Annals of Oncology (9)
  3. Journal for ImmunoTherapy of Cancer (4)
  4. Current Oncology Reports (3)
  5. Future Oncology (3)
  6. Modern Pathology (3)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. Oxford University Press (11)
  3. Biomed Central Ltd (7)
  4. Springer (6)
  5. Future Medicine (5)
  6. Lippincott Williams & Wilkins (5)

More Publishers

Results (97)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The International Association for the Study of Lung Cancer global survey on programmed death-ligand 1 testing for NSCLC
    Journal Article

    Mino-Kenudson, M.; Le Stang, N.; Daigneault, J. B.; Nicholson, A. G.; Cooper, W. A.; Roden, A. C.; Moreira, A. L.; Thunnissen, E.; Papotti, M.; Pelosi, G.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade
    Journal Article

    Zhang, Q.; Luo, J.; Wu, S.; Si, H.; Gao, C.; Xu, W.; Abdullah, S. E.; Higgs, B. W.; Dennis, P. A.; van der Heijden, M. S.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Newcastle disease virus at the forefront of cancer immunotherapy
    Review

    Burman, B.; Pesci, G.; Zamarin, D.
    Cancers (2020)

    Fulltext@MSK | Save
  • Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
    Journal Article

    Motzer, R. J.; Banchereau, R.; Hamidi, H.; Powles, T.; McDermott, D.; Atkins, M. B.; Escudier, B.; Liu, L. F.; Leng, N.; Abbas, A. R.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features
    Review

    Ellis, S. R.; Vierra, A. T.; Millsop, J. W.; Lacouture, M. E.; Kiuru, M.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
    Review

    Gonzalez-Ericsson, P. I.; Stovgaard, E. S.; Sua, L. F.; Reisenbichler, E.; Kos, Z.; Carter, J. M.; Michiels, S.; Le Quesne, J.; Nielsen, T. O.; Lænkholm, A. V.; more...
    Journal of Pathology (2020)

    Fulltext@MSK | Save
  • The promises and challenges of tumor mutation burden as an immunotherapy biomarker: A perspective from the International Association for the Study of Lung Cancer Pathology Committee
    Review

    Sholl, L. M.; Hirsch, F. R.; Hwang, D.; Botling, J.; Lopez-Rios, F.; Bubendorf, L.; Mino-Kenudson, M.; Roden, A. C.; Beasley, M. B.; Borczuk, A.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Updated efficacy results from the JAVELIN Renal 101 trial: First-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
    Journal Article

    Choueiri, T. K.; Motzer, R. J.; Rini, B. I.; Haanen, J.; Campbell, M. T.; Venugopal, B.; Kollmannsberger, C.; Gravis-Mescam, G.; Uemura, M.; Lee, J. L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism
    Journal Article

    Sellam, L. S.; Zappasodi, R.; Chettibi, F.; Djennaoui, D.; Yahi-Ait Mesbah, N.; Amir-Tidadini, Z. C.; Touil-Boukoffa, C.; Ouahioune, W.; Merghoub, T.; Bourouba, M.
    Archives of Biochemistry and Biophysics (2020)

    Fulltext@MSK | Save
  • Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
    Journal Article

    Schoenfeld, A. J.; Rizvi, H.; Bandlamudi, C.; Sauter, J. L.; Travis, W. D.; Rekhtman, N.; Plodkowski, A. J.; Perez-Johnston, R.; Sawan, P.; Beras, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save